Suppressive effects of iron on TGF-β1 production by renal proximal tubular epithelial cells

被引:5
作者
Horino, T
Ito, H
Yamaguchi, T
Furihata, M
Hashimoto, K
机构
[1] Kochi Med Sch, Dept Endocrinol Metab & Nephrol, Nanko Ku, Kochi 7838505, Japan
[2] Kochi Med Sch, Dept Tumor Pathol, Nanko Ku, Kochi 7838505, Japan
来源
NEPHRON EXPERIMENTAL NEPHROLOGY | 2005年 / 100卷 / 01期
关键词
tubulointerstitial fibrosis; cytokine; proteinuria; hematuria; 8-OHdG; oxidative stress;
D O I
10.1159/000084107
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: TGF-beta(1), which is one of the profibrogenic cytokines, is considered essential for both the tubulointerstitial fibrosis found in chronic kidney diseases and the repair of tissue damage in acute renal injury. Iron plays an important part in inflammatory damage since it supplies cytotoxic hydroxyl radicals. The aim of the present study was to examine the direct effects of iron on TGF-beta(1) production and the expression of 8-hydroxy-2'-deoxyguanosine (8-OHdG), a marker of oxidative stress, by human renal proximal tubular epithelial cells (RPTEC). Methods: Using human RPTEC, TGF-beta(1) expression was studied by immunohistochemical staining, ELISA and RNase protection assays. 8-OHdG expression was evaluated by immunohistochemical staining. Results: Ferric iron suppressed both TGF-beta(1) secretion and mRNA expression, and enhanced 8-OHdG expression in RPTEC in a dose-dependent manner. Desferrioxamine, an iron chelator, eliminated the suppressive effect of ferric citrate on TGF-beta(1) production. Conclusions: The results suggest that iron may delay the repair of kidney injury during the acute inflammatory phase via a reduction in TGF-beta(1) production by RPTEC. Iron chelation may therefore be a useful strategy in the treatment of inflammatory kidney diseases. Copyright (C) 2005 S. Karger AG, Basel.
引用
收藏
页码:E1 / E10
页数:10
相关论文
共 40 条
[1]   RENAL IRON HANDLING IN THE NEPHROTIC SYNDROME [J].
ALFREY, AC ;
HAMMOND, WS .
KIDNEY INTERNATIONAL, 1990, 37 (06) :1409-1413
[2]  
BORDER WA, 1994, NEW ENGL J MED, V331, P1286
[3]   TGF-β and fibrosis [J].
Branton, MH ;
Kopp, JB .
MICROBES AND INFECTION, 1999, 1 (15) :1349-1365
[4]   RENAL TUBULAR TRANSPORT AND CATABOLISM OF PROTEINS AND PEPTIDES [J].
CARONE, FA ;
PETERSON, DR ;
OPARIL, S ;
PULLMAN, TN .
KIDNEY INTERNATIONAL, 1979, 16 (03) :271-278
[5]   TRANSFORMING GROWTH FACTOR-BETA-1 AND FACTOR-ALPHA IN CHRONIC LIVER-DISEASE - EFFECTS OF INTERFERON ALFA THERAPY [J].
CASTILLA, A ;
PRIETO, J ;
FAUSTO, N .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (14) :933-940
[6]  
CONRAD ME, 1994, J BIOL CHEM, V269, P7169
[7]   INVITRO AND INVIVO ASSOCIATION OF TRANSFORMING GROWTH FACTOR-BETA-1 WITH HEPATIC-FIBROSIS [J].
CZAJA, MJ ;
WEINER, FR ;
FLANDERS, KC ;
GIAMBRONE, MA ;
WIND, R ;
BIEMPICA, L ;
ZERN, MA .
JOURNAL OF CELL BIOLOGY, 1989, 108 (06) :2477-2482
[8]   HUMAN TRANSFORMING GROWTH FACTOR-BETA COMPLEMENTARY-DNA SEQUENCE AND EXPRESSION IN NORMAL AND TRANSFORMED-CELLS [J].
DERYNCK, R ;
JARRETT, JA ;
CHEN, EY ;
EATON, DH ;
BELL, JR ;
ASSOIAN, RK ;
ROBERTS, AB ;
SPORN, MB ;
GOEDDEL, DV .
NATURE, 1985, 316 (6030) :701-705
[9]   MACROPHAGES, MONOCYTE CHEMOATTRACTANT PEPTIDE-1, AND TGF-BETA-1 IN EXPERIMENTAL HYDRONEPHROSIS [J].
DIAMOND, JR ;
KEESFOLTS, D ;
DING, GH ;
FRYE, JE ;
RESTREPO, NC .
AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 266 (06) :F926-F933
[10]  
FOGAZZI GB, 1995, NEPHROL DIAL TRANSPL, V10, P624